Chun-Su Lee
Comptroller/Controller/Auditor bei NOVMETAPHARMA CO., LTD.
Vermögen: 222 677 $ am 31.05.2024
Aktive Positionen von Chun-Su Lee
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NOVMETAPHARMA CO., LTD. | Comptroller/Controller/Auditor | 31.03.2015 | - |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Comptroller/Controller/Auditor | 01.12.2018 | - |
Karriereverlauf von Chun-Su Lee
Ausbildung von Chun-Su Lee
| Korea University | Graduate Degree |
Statistik
International
| Südkorea | 4 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVMETAPHARMA CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Börse
- Insiders
- Chun-Su Lee
- Erfahrung
